Cargando…
EGFR enhances the stemness and progression of oral cancer through inhibiting autophagic degradation of SOX2
Epidermal growth factor receptor (EGFR) is highly expressed in head and neck squamous cell carcinoma (HNSCC) and correlates with poor prognosis. EGFR has been demonstrated to be associated with cancer stem cell traits in HNSCC. However, the underlying molecular mechanism is far from elucidated. Here...
Autores principales: | Lv, Xiao‐Xi, Zheng, Xiao‐Yu, Yu, Jiao‐Jiao, Ma, Hua‐Rui, Hua, Cheng, Gao, Run‐Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997074/ https://www.ncbi.nlm.nih.gov/pubmed/31823521 http://dx.doi.org/10.1002/cam4.2772 |
Ejemplares similares
-
XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells
por: Ji, Jiao, et al.
Publicado: (2018) -
The anti‐metastatic effect of ginsenoside Rb2 in colorectal cancer in an EGFR/SOX2‐dependent manner
por: Phi, Lan Thi Hanh, et al.
Publicado: (2018) -
Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1
por: Rojansky, Rebecca, et al.
Publicado: (2016) -
Interferon‐induced transmembrane protein 1‐mediated EGFR/SOX2 signaling axis is essential for progression of non‐small cell lung cancer
por: Yang, Ying‐Gui, et al.
Publicado: (2018) -
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription
por: Yu, Jin-mei, et al.
Publicado: (2019)